Boxer Capital as of March 31, 2020
Portfolio Holdings for Boxer Capital
Boxer Capital holds 62 positions in its portfolio as reported in the March 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Mirati Therapeutics | 9.3 | $136M | 1.8M | 76.87 | |
Immunomedics | 7.8 | $114M | 8.5M | 13.48 | |
Beigene (BGNE) | 7.8 | $114M | 925k | 123.11 | |
Odonate Therapeutics Ord | 6.3 | $93M | 3.4M | 27.61 | |
Revolution Medicines (RVMD) | 4.6 | $67M | 3.0M | 21.91 | |
Regeneron Pharmaceuticals (REGN) | 4.5 | $66M | 135k | 488.29 | |
Springworks Therapeutics (SWTX) | 3.8 | $56M | 2.1M | 27.00 | |
Black Diamond Therapeutics (BDTX) | 3.4 | $50M | 2.0M | 24.95 | |
Seattle Genetics | 3.1 | $46M | 400k | 115.38 | |
Sage Therapeutics (SAGE) | 3.0 | $44M | 1.5M | 28.72 | |
Arcus Biosciences Incorporated (RCUS) | 2.9 | $43M | 3.1M | 13.88 | |
Uniqure Nv (QURE) | 2.5 | $36M | 765k | 47.45 | |
Esperion Therapeutics (ESPR) | 2.1 | $31M | 975k | 31.53 | |
Allakos (ALLK) | 2.0 | $30M | 675k | 44.49 | |
Passage Bio (PASG) | 2.0 | $30M | 1.9M | 15.75 | |
Atreca Inc Cl A (BCEL) | 2.0 | $29M | 1.7M | 16.55 | |
Dbv Technologies S A (DBVT) | 1.9 | $28M | 7.0M | 3.92 | |
Argenx Se (ARGX) | 1.8 | $26M | 200k | 131.73 | |
Kadmon Hldgs | 1.8 | $26M | 6.2M | 4.19 | |
Gossamer Bio (GOSS) | 1.5 | $22M | 2.2M | 10.15 | |
Amicus Therapeutics (FOLD) | 1.5 | $22M | 2.3M | 9.24 | |
BioMarin Pharmaceutical (BMRN) | 1.4 | $21M | 250k | 84.50 | |
Rocket Pharmaceuticals (RCKT) | 1.4 | $21M | 1.5M | 13.95 | |
Anaptysbio Inc Common (ANAB) | 1.3 | $18M | 1.3M | 14.13 | |
Bellus Health | 1.2 | $18M | 1.8M | 9.98 | |
Direxion Shs Etf Tr Daily S&p Biotec | 1.2 | $18M | 1.3M | 14.08 | |
Compugen (CGEN) | 1.2 | $17M | 2.4M | 7.26 | |
Trillium Therapeutics, Inc. Cmn | 1.1 | $17M | 4.1M | 4.04 | |
ACADIA Pharmaceuticals (ACAD) | 1.1 | $16M | 370k | 42.25 | |
Ipath Series B S&p500 Vix | 0.9 | $14M | 300k | 46.25 | |
Prevail Therapeutics Ord | 0.9 | $14M | 1.1M | 12.19 | |
Global Blood Therapeutics In | 0.9 | $13M | 250k | 51.09 | |
Neoleukin Therapeutics | 0.8 | $12M | 1.0M | 11.38 | |
Cabaletta Bio (CABA) | 0.8 | $11M | 1.6M | 7.30 | |
Relmada Therapeutics (RLMD) | 0.7 | $10M | 300k | 34.11 | |
Agenus (AGEN) | 0.7 | $9.8M | 4.0M | 2.45 | |
Marinus Pharmaceuticals | 0.7 | $9.7M | 4.8M | 2.03 | |
Amarin Corporation (AMRN) | 0.6 | $9.0M | 2.3M | 4.00 | |
Akero Therapeutics (AKRO) | 0.6 | $8.8M | 417k | 21.20 | |
Axsome Therapeutics (AXSM) | 0.6 | $8.8M | 150k | 58.83 | |
Kura Oncology (KURA) | 0.6 | $8.4M | 845k | 9.95 | |
Syndax Pharmaceuticals (SNDX) | 0.5 | $8.0M | 726k | 10.97 | |
Selecta Biosciences (RNAC) | 0.5 | $7.9M | 3.3M | 2.41 | |
Kodiak Sciences (KOD) | 0.5 | $7.2M | 150k | 47.70 | |
Matinas Biopharma Holdings, In (MTNB) | 0.5 | $6.9M | 12M | 0.60 | |
Xenon Pharmaceuticals (XENE) | 0.5 | $6.8M | 600k | 11.34 | |
Mei Pharma | 0.3 | $4.7M | 2.9M | 1.61 | |
Artara Therapeutics | 0.3 | $4.6M | 200k | 23.00 | |
Kiniksa Pharmaceuticals (KNSA) | 0.3 | $4.5M | 291k | 15.48 | |
Mirum Pharmaceuticals (MIRM) | 0.3 | $4.4M | 317k | 14.00 | |
Zogenix | 0.3 | $4.3M | 175k | 24.73 | |
La Jolla Pharmaceuticl Com Par | 0.3 | $3.7M | 891k | 4.20 | |
Solid Biosciences | 0.2 | $3.7M | 1.5M | 2.39 | |
Barclays Bk Plc cmn | 0.2 | $3.5M | 75k | 46.25 | |
Ideaya Biosciences (IDYA) | 0.2 | $3.1M | 764k | 4.12 | |
Lifesci Acquisition Corp unit 03/31/2025 | 0.2 | $3.0M | 300k | 10.00 | |
Cymabay Therapeutics | 0.2 | $3.0M | 2.0M | 1.48 | |
Mereo Biopharma Group Plc ads (MREO) | 0.2 | $2.6M | 2.5M | 1.05 | |
Milestone Pharmaceuticals (MIST) | 0.1 | $2.0M | 1.1M | 1.84 | |
Cellectar Biosciences | 0.1 | $1.2M | 920k | 1.33 | |
Bellerophon Therapeutics (BLPH) | 0.1 | $1.1M | 99k | 10.96 | |
Zymeworks | 0.1 | $887k | 25k | 35.48 |